D-Mannose
(Synonyms: D-甘露糖) 目录号 : GC33460An aldohexose monosaccharide
Cas No.:3458-28-4
Sample solution is provided at 25 µL, 10mM.
D-Mannose is an aldohexose monosaccharide and an epimer of glucose. D-Mannose is found in animals, microbes, and plants, can be used as an energy source by conversion to glucose, and can also be produced from glucose.1 It is converted via hexokinase to mannose-6-phosphate and then to intermediates that are incorporated into proteins via N-linked glycosylation. It decreases T cell proliferation and increases FoxP3+ T regulatory cells in vitro and prevents diabetes in non-obese diabetic (NOD) mice, a model of autoimmune diabetes, when administered at a dose of 1.1 M in the drinking water.2 D-Mannose administration during gestation at a dose of 9 mg/ml in the drinking water rescues the embryonic lethal phenotype and prevents deficits in glycosylation in Pmm2R137H/F118L mice, a transgenic model of the congenital glycosylation disorder (CDG) PMM2-CDG, which is characterized by phosphomannomutase 2 (PMM2) gene mutations.3 Levels of D-mannose are reduced in the serum of patients with PMM2-CDG.4 Formulations containing D-mannose have been used in the treatment of mannose phosphate isomerase CDG (MPI-CDG).
1.Sharma, V., Ichikawa, M., and Freeze, H.H.Mannose metabolism: More than meets the eyeBiochim. Biophys. Res. Commun.453(2)220-228(2014) 2.Zhang, D., Chia, C., Jiao, X., et al.D-mannose induces regulatory T cells and suppresses immunopathologyNat. Med.23(9)1036-1045(2017) 3.Schneider, A., Theil, C.R., J., DeRossi, C., et al.Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in miceNat. Med.18(1)71-73(2011) 4.Panneerselvam, K., Etchison, J.R., Skovby, F., et al.Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1Biochem. Mol. Med.61(2)161-167(1997)
Cas No. | 3458-28-4 | SDF | |
别名 | D-甘露糖 | ||
Canonical SMILES | OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O | ||
分子式 | C6H12O6 | 分子量 | 180.16 |
溶解度 | Water : ≥ 50 mg/mL (277.53 mM);DMSO : 50 mg/mL (277.53 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.5506 mL | 27.7531 mL | 55.5062 mL |
5 mM | 1.1101 mL | 5.5506 mL | 11.1012 mL |
10 mM | 0.5551 mL | 2.7753 mL | 5.5506 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet